Biohaven (BHVN) Other Non-Current Assets (2021 - 2026)
Biohaven (BHVN) reported Other Non-Current Assets of $45.7 million for Q1 2026, up 18.39% on a YoY basis from $38.6 million in Q1 2025, and down 3.49% sequentially from $47.4 million in Q4 2025.
Biohaven (BHVN) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Other Non-Current Assets data on file, last reported at $45.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 18.39% year-over-year to $45.7 million; the trailing twelve-month figure through Mar 2026 stood at $45.7 million (up 18.39% YoY), and the FY2025 full-year result was $47.4 million, up 19.83% from the prior year.
- Other Non-Current Assets eased to $45.7 million in Q1 2026, from $47.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $48.2 million in Q3 2025 to a low of $17.9 million in Q3 2022.
- A 5-year average of $36.7 million and a median of $36.8 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 159.82% in 2022 and slipped 9.94% in 2023, its largest moves.
- Tracing BHVN's Other Non-Current Assets over 5 years: stood at $37.5 million in 2022, then fell by 9.94% to $33.8 million in 2023, then increased by 16.99% to $39.5 million in 2024, then grew by 19.83% to $47.4 million in 2025, then dropped by 3.49% to $45.7 million in 2026.
- Business Quant data shows BHVN's Other Non-Current Assets at $45.7 million in Q1 2026, $47.4 million in Q4 2025, and $48.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 45.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.71 Mn |
| Dec 31, 2025 | 47.36 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 37.21 Mn |
| Mar 31, 2025 | 38.61 Mn |
| Dec 31, 2024 | 39.53 Mn |
| Sep 30, 2024 | 31.96 Mn |
| Jun 30, 2024 | 32.92 Mn |
| Mar 31, 2024 | 33.31 Mn |
| Dec 31, 2023 | 33.79 Mn |
| Sep 30, 2023 | 34.71 Mn |
| Jun 30, 2023 | 35.55 Mn |
| Mar 31, 2023 | 36.76 Mn |
| Dec 31, 2022 | 37.51 Mn |
| Sep 30, 2022 | 17.88 Mn |
| Dec 31, 2021 | 14.44 Mn |